Natixis Investment Managers International’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-20,675
Closed -$253K 237
2022
Q4
$253K Hold
20,675
0.02% 138
2022
Q3
$256K Sell
20,675
-52,100
-72% -$911K 0.02% 124
2022
Q2
$1.43M Hold
72,775
0.03% 175
2022
Q1
$1.9M Hold
72,775
0.03% 135
2021
Q4
$2.06M Sell
72,775
-8,060
-10% -$251K 0.11% 53
2021
Q3
$2.58M Buy
80,835
+9,885
+14% +$332K 0.15% 47
2021
Q2
$2.46M Buy
+70,950
New +$2.34M 0.15% 49

Other funds holding ELAN

Natixis Investment Managers International's ELAN Position: Q1 2023 in Review

Natixis Investment Managers International sold out of Elanco Animal Health (ELAN) in Q1 2023, closing a stake of 20,675 shares — an estimated $253K sold.

Natixis Investment Managers International first reported a position in ELAN in Q2 2021 and held it in 7 quarters. The position peaked at $2.58M in Q3 2021. 389 funds tracked by Wall St. Rank hold ELAN as of Q1 2023.

  • Natixis Investment Managers International reported no remaining Elanco Animal Health position as of Q1 2023 after selling out during the quarter.
  • Natixis Investment Managers International sold 20,675 Elanco Animal Health shares in Q1 2023, an estimated $253K.
  • Natixis Investment Managers International first reported a position in Elanco Animal Health in Q2 2021 and held it in 7 quarters.
  • Natixis Investment Managers International's Elanco Animal Health position peaked at $2.58M in Q3 2021.
  • 389 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2023.

Based on Natixis Investment Managers International's 13F filing for Q1 2023, filed 12 May 2023.